Edward L. Middleman

Clinical trials with adriamycin

Edward L. Middleman, James K. Luce, Emil Frei · Cancer · 1971 · 227 citations · Full text

Pathology, Pharmacotherapy, Tumor Biology +17

Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer

Charles Butts, David Bodkin, Edward L. Middleman et al. · Journal of Clinical Oncology · 2007 · 196 citations · Full text

Infections in cancer patients.Results with gentamicin sulfate therapy

Gerald P. Bodey, Edward L. Middleman, Theera Umsawadi et al. · Cancer · 1972 · 146 citations · Full text

Cancer Patients.results, Urology, Antimicrobial Susceptibility +15

Antibiotic combinations for infections in neutropenic patients. Evaluation of carbenicillin plus either cephalothin or kanamycin

Edward L. Middleman, Akiko Watanabe, Herbert Kaizer et al. · Cancer · 1972 · 83 citations

Presumed Infection, Pathology, Pharmacotherapy +20

A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer

Thomas J. Lynch, David Fenton, Vera Hirsh et al. · Journal of Thoracic Oncology · 2009 · 64 citations · Full text

Randomized Phase 2, Medicine, Pharmacology +8